Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

Autor: Eur. Orgalutran study group,, Borm, G, Mannaerts, BMJL, de Jong, D (Diederick), Fauser, BCJM (Bart)
Přispěvatelé: Obstetrics & Gynecology
Rok vydání: 2000
Zdroj: Human Reproduction, 15(7), 1490-1498. Oxford University Press
ISSN: 0268-1161
Databáze: OpenAIRE